AVACINCAPTAD PEGOL for Dry age-related macular degeneration: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 93 adverse event reports in the FDA FAERS database where AVACINCAPTAD PEGOL was used for Dry age-related macular degeneration.
Most Reported Side Effects for AVACINCAPTAD PEGOL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Needle issue | 21 | 10.4% | 0 | 0 |
| Intercepted product preparation error | 20 | 9.9% | 0 | 0 |
| No adverse event | 19 | 9.4% | 0 | 0 |
| Off label use | 17 | 8.4% | 0 | 0 |
| Eye pain | 16 | 7.9% | 0 | 0 |
| Vision blurred | 16 | 7.9% | 0 | 0 |
| Syringe issue | 15 | 7.4% | 0 | 0 |
| Visual impairment | 14 | 6.9% | 0 | 0 |
| Endophthalmitis | 13 | 6.4% | 0 | 0 |
| Eye inflammation | 12 | 5.9% | 0 | 0 |
| Intraocular pressure increased | 12 | 5.9% | 0 | 0 |
| Vitritis | 11 | 5.5% | 0 | 0 |
| Device issue | 10 | 5.0% | 0 | 0 |
| Vitreous floaters | 10 | 5.0% | 0 | 0 |
| Uveitis | 9 | 4.5% | 0 | 0 |
Other Indications for AVACINCAPTAD PEGOL
Product used for unknown indication (87)
Age-related macular degeneration (13)
Macular degeneration (7)
Other Drugs Used for Dry age-related macular degeneration
PEGCETACOPLAN (326)
FARICIMAB\FARICIMAB-SVOA (92)
RANIBIZUMAB (81)
AFLIBERCEPT (70)
BEVACIZUMAB (28)
FARICIMAB-SVOA (19)
INVESTIGATIONAL PRODUCT (7)
VITAMINS (7)
MINERALS\VITAMINS (5)